Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
94.7M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
79.5M
-
Shares change
-
+2.03M
-
Total reported value, excl. options
-
$892M
-
Value change
-
+$26.4M
-
Put/Call ratio
-
0.65
-
Number of buys
-
48
-
Number of sells
-
-46
-
Price
-
$11.22
Significant Holders of Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) as of Q2 2023
112 filings reported holding ENFN - Enfusion Inc. - Common Stock, Par Value $0.001 as of Q2 2023.
Enfusion Inc. - Common Stock, Par Value $0.001 (ENFN) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
of 94.7M outstanding shares and own 83.92% of the company stock.
Largest 10 shareholders include FTV Management Company, L.P. (32.4M shares), ICONIQ Capital, LLC (14M shares), BROWN CAPITAL MANAGEMENT LLC (9.62M shares), HHLR ADVISORS, LTD. (4.98M shares), VANGUARD GROUP INC (2.98M shares), Ararat Capital Management LP (2.44M shares), 12 West Capital Management LP (1.9M shares), BlackRock Inc. (1.59M shares), JANUS HENDERSON GROUP PLC (1.46M shares), and NEW YORK STATE COMMON RETIREMENT FUND (1.38M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.